In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022).
María García-CastilloMarta Hernandez-GarcíaAdriana CorreaMarco CoppiThomas GrienerThomas FritscheCristina PitartJorge SampaioHarald SeifertKaren WakeMandy WoottonJordi VilaRafael CantónPublished in: JAC-antimicrobial resistance (2024)
Ozenoxacin is a potent antimicrobial agent of topic use against Gram-positive bacteria causing SSTI, including MRSA isolates non-susceptible to ciprofloxacin.